Literature DB >> 24732764

Neural retinal regeneration with pluripotent stem cells.

Conor M Ramsden1, Michael B Powner, Amanda-Jayne F Carr, Matthew J K Smart, Lyndon da Cruz, Peter J Coffey.   

Abstract

Retinal degeneration represents a huge burden of blinding disease, and currently there are no effective treatments that reverse the most common causes of neural retinal degeneration. Stem cell biology has the potential to significantly ease this burden, not only through the development of disease models of retinal degeneration but also in the manufacture of a replacement for the neural retinal tissue. This review summarizes the major advancements in the last decade in the field of neural retinal regeneration with an emphasis on the differentiation of embryonic and induced pluripotent stem cells into cells with retinal and specifically photoreceptor characteristics.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24732764     DOI: 10.1159/000357363

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  4 in total

Review 1.  Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.

Authors:  Melissa K Jones; Bin Lu; Sergey Girman; Shaomei Wang
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

Review 2.  Using Stem Cells to Model Diseases of the Outer Retina.

Authors:  Camille Yvon; Conor M Ramsden; Amelia Lane; Michael B Powner; Lyndon da Cruz; Peter J Coffey; Amanda-Jayne F Carr
Journal:  Comput Struct Biotechnol J       Date:  2015-05-06       Impact factor: 7.271

3.  Early retinal differentiation of human pluripotent stem cells in microwell suspension cultures.

Authors:  Vishal S Sharma; Rana Khalife; Rui Tostoes; Leonard Leung; Rose Kinsella; Ludmilla Ruban; Farlan S Veraitch
Journal:  Biotechnol Lett       Date:  2016-11-03       Impact factor: 2.461

Review 4.  Using magnetic resonance imaging to assess visual deficits: a review.

Authors:  Holly D H Brown; Rachel L Woodall; Rebecca E Kitching; Heidi A Baseler; Antony B Morland
Journal:  Ophthalmic Physiol Opt       Date:  2016-05       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.